ARECOR THERAPEUTICS PLC Logo

ARECOR THERAPEUTICS PLC

AREC | IL

Overview

Corporate Details

ISIN(s):
GB00BMWLM973
LEI:
98450093D12I3A8DDD58
Country:
United Kingdom
Address:
Chesterford Research Park, CB10 1XL Saffron Walden
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Arecor Therapeutics plc is a globally focused biopharmaceutical company that develops enhanced therapeutic medicines by applying its proprietary Arestat™ technology platform. The company's primary business involves reformulating existing pharmaceutical products to improve their stability, efficacy, and delivery methods, thereby transforming patient care. Arecor operates a dual business model: developing its own proprietary portfolio of medicines, with a key focus on treatments for diabetes and obesity (such as an oral GLP-1 agonist), and partnering with leading pharmaceutical and medtech companies to enhance their therapeutic products. The Arestat™ platform is supported by a robust intellectual property portfolio and aims to address significant unmet patient needs in high-value markets.

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for ARECOR THERAPEUTICS PLC. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-08-28 13:00
Major Shareholding Notification
Holding(s) in Company
English 23.4 KB
2025-08-08 08:00
Audit Report / Information
Change of Auditor
English 13.2 KB
2025-07-14 08:00
Regulatory News Service
Arecor Establishes New Scientific Advisory Board
English 18.0 KB
2025-06-02 14:32
Post-Annual General Meeting Information
Result of AGM
English 25.5 KB
2025-06-02 08:00
Board/Management Information
Non-Executive Director Board Change
English 15.2 KB
2025-05-06 17:42
Report Publication Announcement
Posting of 2024 Annual Report and Notice of AGM
English 13.6 KB
2025-04-22 08:00
Annual Report
Final results for 2024
English 334.0 KB
2025-03-26 08:00
M&A Activity
Collaboration with global pharmaceutical partner
English 16.3 KB
2025-03-12 08:00
Regulatory News Service
Arecor partnership with biopharmaceutical company
English 17.5 KB
2025-02-03 08:00
Earnings Release
Arecor Full Year 2024 Trading Update
English 20.8 KB
2025-01-10 08:45
M&A Activity
Orderly Cessation of Tetris Pharma Operations
English 19.2 KB
2025-01-09 08:00
Board/Management Information
Change of Nominated Advisor and Joint Broker
English 12.7 KB
2024-12-30 08:00
Regulatory News Service
Arecor Signs Exclusive Licensing Agreement
English 18.9 KB
2024-12-02 08:00
Remuneration Information
Grant of Options and PDMR Dealing
English 23.5 KB
2024-11-18 08:00
Board/Management Information
Arecor Appoints Interim Chief Financial Officer
English 12.0 KB

Automate Your Workflow. Get a real-time feed of all ARECOR THERAPEUTICS PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for ARECOR THERAPEUTICS PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
4BASEBIO PLC Logo
Manufactures GMP-compliant synthetic DNA for advanced therapies, vaccines, and cell/gene therapies.
United Kingdom 4BB
ABINGDON HEALTH PLC Logo
A CDMO for lateral flow rapid tests, providing end-to-end services and its own branded products.
United Kingdom ABDX
ABIONYX Pharma Logo
Biotech developing lipid-based therapies for rare renal and ophthalmological diseases.
France ABNX
AB Science Logo
Develops protein kinase inhibitors for oncology, neuro, and inflammatory diseases.
France AB
AcuCort AB Logo
Develops a rapid oral film for acute allergies, croup, and chemo-induced nausea.
Sweden ACUC
Advicenne Logo
Develops and commercializes therapies for rare renal diseases for patients of all ages.
France ALDVI
AegirBio AB Logo
Makes saliva-based diagnostics accessible for at-home & pro health & drug monitoring.
Sweden AEGIR
Aelis Farma Logo
Developing novel CB1 receptor inhibitors for treating brain and CNS disorders.
France AELIS
AGRONOMICS LIMITED Logo Isle of Man ANIC
ALK-Abelló Logo
Develops allergy immunotherapy (AIT) and emergency treatments for severe allergies.
Denmark ALK